161
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Advanced Lung Cancer Inflammation Index for Predicting Prognostic Risk for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

ORCID Icon, ORCID Icon, , ORCID Icon, , , & show all
Pages 3631-3641 | Received 28 May 2023, Accepted 15 Aug 2023, Published online: 23 Aug 2023

References

  • Bhatt DL, Lopes RD, Harrington RA. Diagnosis and treatment of acute coronary syndromes: a review. JAMA. 2022;327(7):662–675. doi:10.1001/jama.2022.0358
  • Hoole SP, Bambrough P. Recent advances in percutaneous coronary intervention. Heart. 2020;106(18):1380–1386. doi:10.1136/heartjnl-2019-315707
  • Kamran H, Jneid H, Kayani WT, et al. Oral antiplatelet therapy after acute coronary syndrome: a review. JAMA. 2021;325(15):1545–1555. doi:10.1001/jama.2021.0716
  • Serruys PW, Hara H, Garg S, et al. Coronary computed tomographic angiography for complete assessment of coronary artery disease: JACC state-of-The-art review. J Am Coll Cardiol. 2021;78(7):713–736. doi:10.1016/j.jacc.2021.06.019
  • Awesat J, Abitbol M, Vons S, Eisen A, Porter A. Current challenges in the diagnosis and management of acute coronary syndromes in women. Kardiol Pol. 2022;80(11):1084–1093. doi:10.33963/KP.a2022.0254
  • Eisen A, Giugliano RP, Braunwald E. Updates on acute coronary syndrome: a review. JAMA Cardiol. 2016;1(6):718–730. doi:10.1001/jamacardio.2016.2049
  • Han K, Shi D, Yang L, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ann Med. 2022;54(1):1667–1677. doi:10.1080/07853890.2022.2083671
  • Syed Soffian SS, Mohammed Nawi A, Hod R, et al. Meta-analysis of the association between dietary inflammatory index (DII) and colorectal cancer. Nutrients. 2022;14(8):1555. doi:10.3390/nu14081555
  • Huang H, Liu Q, Zhu L, et al. Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer. Sci Rep. 2019;9(1):3284. doi:10.1038/s41598-019-39150-0
  • Jafri SH, Shi R, Mills G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer. 2013;13(1):158. doi:10.1186/1471-2407-13-158
  • Henein MY, Vancheri S, Longo G, Vancheri F. The role of inflammation in cardiovascular disease. Int J Mol Sci. 2022;23(21):12906. doi:10.3390/ijms232112906
  • Fan W, Zhang Y, Gao X, et al. The prognostic value of a derived neutrophil-lymphocyte ratio in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Clin Appl Thromb Hemost. 2021;27:107602962110345. doi:10.1177/10760296211034579
  • Liu XR, Wang LL, Zhang B, et al. The advanced lung cancer inflammation index is a prognostic factor for gastrointestinal cancer patients undergoing surgery: a systematic review and meta-analysis. World J Surg Oncol. 2023;21(1):81. doi:10.1186/s12957-023-02972-4
  • Zhang Y, Chen B. Prognostic value of the advanced lung cancer inflammation index in patients with lung cancer: a meta-analysis. Dis Markers. 2019;2019:2513026. doi:10.1155/2019/2513026
  • Xie H, Huang S, Yuan G, et al. The advanced lung cancer inflammation index predicts short and long-term outcomes in patients with colorectal cancer following surgical resection: a retrospective study. PeerJ. 2020;8:e10100. doi:10.7717/peerj.10100
  • Fan W, Zhang Y, Liu Y, et al. Nomograms based on the advanced lung cancer inflammation index for the prediction of coronary artery disease and calcification. Clin Appl Thromb Hemost. 2021;27:107602962110604. doi:10.1177/10760296211060455
  • Fan W, Liu Y, Zhang Y, et al. Prognostic value of a novel dNLR-PNI score in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Perfusion. 2022;38(5):973–982. doi:10.1177/02676591221090620
  • Locuratolo N, Scicchitano P, Antoncecchi E, et al. Follow-up of patients after an acute coronary event: the Apulia PONTE-SCA program. G Ital Cardiol. 2022;23(1):63–74. doi:10.1714/3715.37064
  • Zhang L, Zhao K, Kuang T, et al. The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy. BMC Cancer. 2023;23(1):101. doi:10.1186/s12885-023-10570-6
  • Chen H, Zhang F, Luo D, et al. Advanced lung cancer inflammation index predicts the outcomes of patients with non-metastatic gastric cancer after radical surgical resection. J Gastrointest Oncol. 2023;14(1):85–96. doi:10.21037/jgo-22-657
  • Song M, Zhang Q, Song C, et al. The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer. J Cachexia Sarcopenia Muscle. 2022;13(5):2504–2514. doi:10.1002/jcsm.13032
  • Houston M. The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease. Ther Adv Cardiovasc Dis. 2018;12(3):85–108. doi:10.1177/1753944717743920
  • Renaud S, de Lorgeril M. Nutrition, atherosclerosis and coronary heart disease. Reprod Nutr Dev. 1994;34(6):599–607. doi:10.1051/rnd:19940606
  • Mao W, Wang K, Wu Y, et al. Prognostic significance of modified advanced lung cancer inflammation index in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: a multi-institutional, propensity score matching cohort study. Front Nutr. 2021;8:781647. doi:10.3389/fnut.2021.781647
  • Yin C, Toiyama Y, Okugawa Y, et al. Clinical significance of advanced lung cancer inflammation index, a nutritional and inflammation index, in gastric cancer patients after surgical resection: a propensity score matching analysis. Clin Nutr. 2021;40(3):1130–1136. doi:10.1016/j.clnu.2020.07.018
  • Poznyak AV, Grechko AV, Orekhova VA, Khotina V, Ivanova EA, Orekhov AN. NADPH oxidases and their role in atherosclerosis. Biomedicines. 2020;8(7):206. doi:10.3390/biomedicines8070206
  • Ridker PM, Everett BM, Pradhan A, et al. Low-dose methotrexate for the prevention of atherosclerotic events. N Engl J Med. 2019;380(8):752–762. doi:10.1056/NEJMoa1809798
  • Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131. doi:10.1056/NEJMoa1707914
  • Ma J, Chen X. Anti-inflammatory therapy for coronary atherosclerotic heart disease: unanswered questions behind existing successes. Front Cardiovasc Med. 2020;7:631398. doi:10.3389/fcvm.2020.631398
  • Döring Y, Soehnlein O, Weber C. Neutrophil extracellular traps in atherosclerosis and atherothrombosis. Circ Res. 2017;120(4):736–743. doi:10.1161/CIRCRESAHA.116.309692
  • Saigusa R, Winkels H, Ley K. T cell subsets and functions in atherosclerosis. Nat Rev Cardiol. 2020;17(7):387–401. doi:10.1038/s41569-020-0352-5
  • Balta S, Celik T, Mikhailidis DP, et al. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost. 2016;22(5):405–411. doi:10.1177/1076029615569568
  • Marin BS, Cesena F, Laurinavicius AG, Santos RD, Bittencourt MS. Neutrophil-to-lymphocyte ratio and abdominal aortic atherosclerosis among asymptomatic individuals. Arq Bras Cardiol. 2022;118(4):729–734. doi:10.36660/abc.20201163